IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease.

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

Jennifer Klumas is a Mainer with Alzheimer's and shared her story with CBS13. She worked as a TV commercial producer for decades and in the last few years she noticed she couldn't remember how to do ...

"On behalf of everyone who could benefit from this treatment, we strongly urge the FDA to move swiftly in this next stage of its review," the group said. The news comes after the first Alzheimer's ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

NASHVILLE, Tenn. (WSMV) - KCA Neurology in Middle Tennessee has recently launched a National Institutes of Health-funded ...

Denali Therapeutics Inc. DNLI announced that its meeting with the Center for Drug Evaluation and Research (“CDER”) division of the FDA for the advancement of ... beta for the potential treatment of ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a collaboration with Eli Lilly and Company to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) ...

Sean McClain, founder and CEO of Absci, which is finding novel therapies using digital twins combined with generative AI, is similarly bullish about decreasing the approval ... drug trial, in other ...

In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion ...

Egret Therapeutics today announced the appointment of Dr. Ron Cohen to its Board of Directors. "We are thrilled to welcome Ron to Egret's Board of Directors. His extensive experience and expertise ...